Resistance Exercise Training, a Simple Intervention to Preserve Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy

Int J Sport Nutr Exerc Metab. 2023 Dec 4;34(2):122-134. doi: 10.1123/ijsnem.2023-0075. Print 2024 Mar 1.

Abstract

Androgen deprivation therapy (ADT) forms the cornerstone in the treatment of advanced prostate cancer. However, by suppressing testosterone ADT results in a decrease of skeletal muscle mass. In this narrative review, we explore the magnitude and mechanisms of ADT-induced muscle mass loss and the consequences for muscle strength and physical performance. Subsequently, we elucidate the effectiveness of supervised resistance exercise training as a means to mitigate these adverse effects. Literature shows that resistance exercise training can effectively counteract ADT-induced loss of appendicular lean body mass and decline in muscle strength, while the effect on physical performances is inconclusive. As resistance exercise training is feasible and can be safely implemented during ADT (with special attention for patients with bone metastases), it should be incorporated in standard clinical care for prostate cancer patients (starting) with ADT.

Keywords: hormonal therapy; lean body mass; strength training.

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / adverse effects
  • Androgens
  • Body Composition
  • Humans
  • Male
  • Muscle Strength / physiology
  • Muscles
  • Prostatic Neoplasms* / chemically induced
  • Prostatic Neoplasms* / drug therapy
  • Resistance Training* / methods

Substances

  • Androgen Antagonists
  • Androgens